Home
Conditions
Flaviviridae Infections

Clinical trial condition

Flaviviridae Infections

Explore clinical trials studying Flaviviridae Infections. Study availability and eligibility vary by location and protocol.

2,145 public trials 77 recruiting studies

Refine in advanced search Browse all conditions

Flaviviridae Infections trial results

Completed

A Study of MDX-1106 to Treat Patients With Hepatitis C Infection

NCT00703469

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Advanced Clinical Resesarch Institute Anaheim, California, United States

Quest Clinical Research San Francisco, California, United States

Springfield Clinic Infectious Diseases Springfield, Illinois, United States

John Hopkins University School of Medicine, Viral Hepatitis Center Baltimore, Maryland, United States

View Trial Details

Completed

A Study to Examine the Effects of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus in Healthy Adults

NCT01038167

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Dallas, Texas, United States

View Trial Details

Completed

Antiviral Activity of AZD7295 in HCV Carriers

NCT00781976

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Prof Ed Gane Auckland, New Zealand

View Trial Details

Completed

Hepatitis C: Grading and Staging by MR

NCT00059397

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Fourteen Day Safety of Low-Dose Tamoxifen in Patients With Chronic Hepatitis C Who Have Failed Standard Medical Therapy

NCT00749138

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: VA Hospital Oklahoma City, Oklahoma, United States

View Trial Details

Completed

Prophylaxis of Psychiatric Symptoms During Anti-HCV Treatment

NCT00133276

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Erasmus MC University Hospital Rotterdam, South Holland, Netherlands

AMC Amsterdam, Netherlands

Radboud University Hospital Nijmegen, Netherlands

View Trial Details

Completed

Clinical Pharmacology Study of AZD7295 in Healthy Subjects

NCT00906256

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Pharmaceutical Profiles Ltd Nottingham, United Kingdom

View Trial Details

Completed

Individually Adapted Therapy Duration for the Treatment of Chronic Hepatitis C Genotype 1 Infection

NCT00351403

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Medizinische Universitätsklinik Freiburg Freiburg im Breisgau, Baden-Wurttemberg, Germany

Universitätsklinik Heidelberg Heidelberg, Baden-Wurttemberg, Germany

Universitätsklinikum Ulm Ulm, Baden-Wurttemberg, Germany

Uniklinikum Erlangen Erlangen, Bavaria, Germany

View all 22 locations

View Trial Details

Completed

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

NCT00445419

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Vaccine and Immunotherapy Center, CHUV Lausanne, Switzerland

View Trial Details

Completed

Safety of and Immune Response of a 2-dose Regimen of rDEN1delta30 Dengue Virus Vaccine

NCT00473135

Conditions: Arbovirus Infections, Dengue, Flaviviridae Infections, +8 more
Locations: Center for Immunization Research, Johns Hopkins School of Public Health Baltimore, Maryland, United States

View Trial Details

Flaviviridae Infections

Flaviviridae Infections trial results

Related conditions